Serum IFN Score May Predict Outcome in Diffuse Cutaneous SSc

TOPLINE: High serum type I interferon (IFN) scores, measured through six chemokines, correlated with poorer lung function and health-related quality of life in patients with diffuse cutaneous systemic sclerosis (SSc). METHODOLOGY: A retrospective cohort study analyzed two cohorts of patients with diffuse cutaneous SSc from the United States and the United Kingdom using a six-analyte ...

Market Touch Signal is a free discovery window from Oy Market Touch Ltd. Practical intelligence, clear communication and useful digital ventures: https://market-touch.org/
Get In Touch

Market Touch Signal · Finland · international digital desk

+358 400 512311

info@market-touch.org

Follow Us
Flickr Photos
© 2026 Oy Market Touch Ltd. · Market Touch Signal